SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on April 12, 2021. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM. The report primarily serves to disclose a scheduled presentation by the Chairman and CEO at the Annual Needham Virtual Healthcare Conference.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure of a corporate event rather than a financial statement.
Material Changes
No material financial changes or operational updates are detailed in the text of this filing. The report focuses solely on the announcement of an upcoming investor presentation.
Guidance, Outlook, and Risks
Management Commentary: Kenneth L. Londoner, Executive Chairman, is scheduled to present at the Annual Needham Virtual Healthcare Conference on April 12, 2021, at 3:00 PM ET. The slide deck is attached as Exhibit 99.1.
Forward-Looking Statements: The Company explicitly states it undertakes no obligation to update, supplement, or amend the presentation materials.
Legal Disclaimer: In accordance with General Instruction B.2 of Form 8-K, the information in Item 7.01 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section. The Company does not determine that the information is material or required by Regulation FD.
Key Facts for Investor Verification
- Verify the content of the attached slide presentation (Exhibit 99.1) for any specific business updates or financial projections not included in the main text.
- Confirm the trading status of BSGM on the NASDAQ Capital Market.
- Note that the presentation materials are not legally "filed" and the company disclaims any obligation to update them.
- Review subsequent filings for actual financial performance data, as this 8-K contains no quantitative financial results.